HILLSBOROUGH, CA, March 04, 2026 /24-7PressRelease/ -- Elham Nejati, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Nejati is widely recognized for her expertise in drug delivery, particularly in the development of long-acting oral medications and injectables, and her tenure at Gilead Sciences Inc. has been marked by progressive leadership and technical innovation. Since 2025, she has thrived as the senior director of formulation and process development, partnering with a team of principal scientists and directors. In this capacity, she leads the Chemistry, Manufacturing and Controls efforts for multiple drugs, guiding them from clinical phases to commercialization. Additionally, Dr. Nejati interacts with regulatory agencies to secure drug approvals, authors reports for regulatory filings and supports research teams in developing new drugs and formulations.

From 2020 to 2025, Dr. Nejati excelled as the director of formulation and process development at Gilead Sciences Inc., where she managed cross-functional teams and played a pivotal role in advancing several pharmaceutical products through various stages of development. Her service as a senior research scientist II for the organization between 2018 and 2020 was distinguished by her signature technical contributions to formulation strategies, which ultimately improved drug efficacy and patient outcomes. Additionally, Dr. Nejati served as a senior research scientist I at Gilead Sciences, focusing on optimizing processes for oral solid dosage forms in 2018.

Between 2015 and 2017, Dr. Nejati worked at the rank of research scientist II in formulation and process development at Gilead Sciences, contributing to the design and scale-up of manufacturing processes for investigational drugs. Her foundational years at the firm included work as a research scientist I in formulation and process development in 2012 and as a research intern in formulation and process development in 2011; in each successive role, Dr. Nejati advanced her skills in pharmaceutical formulation while collaborating closely with multidisciplinary teams.

A passion for continuous learning drove Dr. Nejati to pursue academic excellence. She holds a Bachelor of Science in materials science and engineering from Sharif University of Technology, completed in 2004, and a Master of Science in biomedical engineering from Amirkabir University of Technology – Tehran Polytechnic, earned in 2007. Subsequently, Dr. Nejati pursued a Master of Science in biomedical-medical engineering at the University of Wisconsin-Madison, which she finished in 2009. She also holds a Doctor of Philosophy in pharmaceutical sciences from the University of Wisconsin-Madison School of Pharmacy, conferred in 2012, and during her studies for the terminal degree, Dr. Nejati served as a research and teaching assistant in pharmaceutical sciences.

Throughout her academic journey, Dr. Nejati benefited from the guidance of mentors who contributed to her professional growth. She counts her collaborative work on introducing Vosevi, an acute medication for Hepatitis C virus infection, as a testament to her enduring commitment to improving patient care through innovative therapies. Notably, Dr. Nejati's technical acumen is further evidenced by three patents on long-acting injectables and two patents for oral solid dosage forms.

Driven to serve, Dr. Nejati is a supporter of the Pars Equality Center, an organization dedicated to social welfare and community support. Since 2025, she has also held a seat on the board of directors for the Enabling Technologies Consortium, and Dr. Nejati was a member of the IQ Consortium from 2024 to January 2026.

Dr. Nejati cherishes spending time with her son, and she prioritizes an active lifestyle and travel experiences. Looking toward the future, Dr. Nejati will persist in advancing her work at Gilead Sciences Inc. and gaining valuable experience that will prepare her for future endeavors, including establishing her own drug delivery consulting firm.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #